Luteolin and Estrogen Receptor Inhibition in HepG2 Cells
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization :
Other organizations : Hainan Medical University
Variable analysis
- Luteolin concentration (5, 10, 20, 40, 80, 160, and 320 μmol/L)
- Fulvestrant concentration (1, 20, 50, 100, 300, 500, and 900 nmol/L)
- Akt agonist SC79 (10 μmol/L)
- MAPK-JNK agonist anisomycin (4 μmol/L)
- Effect of luteolin on HepG2 cells
- Effect of ESR1 inhibition on HepG2 cells
- Effect of Akt and MAPK-JNK signaling on ESR1 expression
- HepG2 cells (Cell Bank of Chinese Academy of Sciences)
- DMEM (BI, Israel) containing 10% fetal bovine serum (FBS; Gibco)
- Incubation at 37°C with 5% CO2
- DMSO as control
- DMSO as a control
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!